Galvani Bioelectronics
Pre-clinicalSplenic nerve stimulation is a novel approach to modulate the immune system for Rheumatoid Arthritis.
Founded
2016
Focus
Digital HealthNeuroscience
About
Splenic nerve stimulation is a novel approach to modulate the immune system for Rheumatoid Arthritis.
Funding History
1Total raised: $715M
Series A$715MGoogleAug 15, 2016
Company Info
TypePrivate
Founded2016
LocationBrentford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile